Background
==========

To improve the quality of care for patients with JIA, standardization of treatment is mandatory. We present a clinical practice guideline (CPG) for the treatment of JIA. It is based on the existing CPG of 2005^\*^ and 2008^\#^ (^\*^published as book chapter; ^\#^peer reviewed publication: Clinical Research and Practice in Paediatrics 2008; 220: 392 - 402).

Methods
=======

We performed a systematic literature analysis in PubMed (deadline: 15^th^ January 2010, terms \"juvenile idiopathic (rheumatoid) arthritis\", \"therapy\", limits: "humans", "published in the last 3 years", "all child 0-18 years", "clinical trial") and evaluated relevant studies for quality of methodology. A formal consensus process, i.e. Nominal group technique and Delphi method, was conducted at three moderated consensus conferences at Düsseldorf or Krefeld (Germany) on May 9^th^, 2007, August 1^st^, 2007 and January 15^th^, 2010. Conferences were attended by 95% of the representatives who had been nominated by their scientific society or organizations.

Results
=======

15 consensus statements and key notes regarding drug therapy, symptomatic and surgical management of JIA were compiled and judged strictly by the criteria of Evidence-Based Medicine (presented on the poster).

Conclusions
===========

Currently, we recommend that JIA is treated with NSAR followed by local GC and/ or MTX as first line treatment. Other interventions e. g. the role of biologic agents, physiotherapy, and arthroscopy are discussed strictly on the basis of literature available. Our CPG will require a frequent update, as the number of randomized trials is increasing and the new potential drugs will become available.
